BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 32809911)

  • 1. Statement of Retraction: Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Cancer Biol Ther; 2020 Sep; 21(9):871. PubMed ID: 32809911
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
    Sun L; Liu L; Yang J; Li H; Zhang C
    J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis.
    Huang B; Chang C; Wang BL; Li H
    J Cell Biochem; 2019 Oct; 120(10):16921-16933. PubMed ID: 31104318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells.
    Bjeije H; Soltani BM; Behmanesh M; Zali MR
    Hum Mol Genet; 2019 Oct; 28(19):3219-3231. PubMed ID: 31238337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.
    Zhang Y; Li J; Jia S; Wang Y; Kang Y; Zhang W
    Biochem Cell Biol; 2019 Apr; 97(2):193-200. PubMed ID: 30352165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Integrated analysis of DNA methylation and gene expression profiles of hepatocellular carcinoma to construct miR-1180-3p relevant ceRNA regulatory network].
    Zhou ZH; Zhou XG; Zhou ZW; Qiu MQ; Jiang YJ; Lin QL; Liu YC; Wen QP; Huo RR; Liang XM; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):481-487. PubMed ID: 32660176
    [No Abstract]   [Full Text] [Related]  

  • 11. LncRNA SNHG20 contributes to cell proliferation and invasion by upregulating ZFX expression sponging miR-495-3p in gastric cancer.
    Cui N; Liu J; Xia H; Xu D
    J Cell Biochem; 2019 Mar; 120(3):3114-3123. PubMed ID: 30520073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer.
    Eissa S; Safwat M; Matboli M; Zaghloul A; El-Sawalhi M; Shaheen A
    Urol Oncol; 2019 Apr; 37(4):292.e19-292.e27. PubMed ID: 30654976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer.
    Li P; Xing W; Xu J; Yuan D; Liang G; Liu B; Ma H
    Stem Cell Res Ther; 2019 May; 10(1):144. PubMed ID: 31113460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer.
    Yuan H; Chen Z; Bai S; Wei H; Wang Y; Ji R; Guo Q; Li Q; Ye Y; Wu J; Zhou Y; Qiao L
    Cancer Lett; 2018 Apr; 418():84-96. PubMed ID: 29337109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
    Yang JX; Liu B; Yang BY; Meng Q
    Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
    Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
    Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p.
    Luo M; Liang C
    Biol Res; 2020 Apr; 53(1):14. PubMed ID: 32293550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of long noncoding RNA NEAT1 attenuates hypoxia-induced cardiomyocytes injury by targeting miR-378a-3p.
    Zhao J; Chen F; Ma W; Zhang P
    Gene; 2020 Mar; 731():144324. PubMed ID: 31904498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression.
    Wu Y; Tao L; Liang J; Qiao Y; Liu W; Yu H; Yu X; Liu L
    Exp Ther Med; 2020 Aug; 20(2):952-960. PubMed ID: 32765654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.